JP2019535265A5 - - Google Patents

Download PDF

Info

Publication number
JP2019535265A5
JP2019535265A5 JP2019524951A JP2019524951A JP2019535265A5 JP 2019535265 A5 JP2019535265 A5 JP 2019535265A5 JP 2019524951 A JP2019524951 A JP 2019524951A JP 2019524951 A JP2019524951 A JP 2019524951A JP 2019535265 A5 JP2019535265 A5 JP 2019535265A5
Authority
JP
Japan
Prior art keywords
population
cells
days
item
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019524951A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019535265A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/061541 external-priority patent/WO2018090002A1/en
Publication of JP2019535265A publication Critical patent/JP2019535265A/ja
Publication of JP2019535265A5 publication Critical patent/JP2019535265A5/ja
Priority to JP2022072292A priority Critical patent/JP2022090133A/ja
Pending legal-status Critical Current

Links

JP2019524951A 2016-11-14 2017-11-14 幹細胞由来シュワン細胞 Pending JP2019535265A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022072292A JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662421816P 2016-11-14 2016-11-14
US62/421,816 2016-11-14
PCT/US2017/061541 WO2018090002A1 (en) 2016-11-14 2017-11-14 Stem cell derived schwann cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022072292A Division JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Publications (2)

Publication Number Publication Date
JP2019535265A JP2019535265A (ja) 2019-12-12
JP2019535265A5 true JP2019535265A5 (enExample) 2021-04-08

Family

ID=62110088

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019524951A Pending JP2019535265A (ja) 2016-11-14 2017-11-14 幹細胞由来シュワン細胞
JP2019524940A Pending JP2019535263A (ja) 2016-11-14 2017-11-14 幹細胞由来シュワン細胞を使用する薬物発見のための方法
JP2022022796A Pending JP2022059056A (ja) 2016-11-14 2022-02-17 幹細胞由来シュワン細胞を使用する薬物発見のための方法
JP2022072292A Pending JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019524940A Pending JP2019535263A (ja) 2016-11-14 2017-11-14 幹細胞由来シュワン細胞を使用する薬物発見のための方法
JP2022022796A Pending JP2022059056A (ja) 2016-11-14 2022-02-17 幹細胞由来シュワン細胞を使用する薬物発見のための方法
JP2022072292A Pending JP2022090133A (ja) 2016-11-14 2022-04-26 幹細胞由来シュワン細胞

Country Status (9)

Country Link
US (2) US20190331666A1 (enExample)
EP (2) EP3538115A4 (enExample)
JP (4) JP2019535265A (enExample)
KR (1) KR20190077095A (enExample)
CN (2) CN110691601A (enExample)
AU (2) AU2017357072A1 (enExample)
CA (2) CA3043223A1 (enExample)
IL (2) IL266524A (enExample)
WO (2) WO2018090002A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL272246B1 (en) 2017-07-28 2025-09-01 Applied Therapeutics Inc Derivatives of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as aldose reductase inhibitors in treating galactosemia or preventing complications associated with galactosemia
CN111655336A (zh) * 2017-11-17 2020-09-11 纽约州立大学研究基金会 使用x射线微束辐射治疗受损周围神经的方法
AU2018379993A1 (en) * 2017-12-04 2020-07-02 Axosim, Inc. Cell systems using spheroids and methods of making and using the same
AU2020210630B2 (en) 2019-01-23 2025-10-23 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
US11845989B2 (en) 2019-01-23 2023-12-19 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
CN113966396A (zh) 2019-05-07 2022-01-21 迈阿密大学 遗传性神经病和相关障碍的治疗和检测
CN110157660A (zh) * 2019-06-10 2019-08-23 西安飞如生物科技有限公司 诱导成纤维细胞分泌抗菌肽的诱导培养基和方法、成纤维细胞及应用
JPWO2021166984A1 (enExample) * 2020-02-20 2021-08-26
EP3929281A1 (en) 2020-06-24 2021-12-29 Fachhochschule Technikum Wien Cell construct comprising schwann cells or schwann cell-like cells and a biocompatible matrix
EP4298219A1 (en) 2021-02-26 2024-01-03 Regeneron Pharmaceuticals, Inc. Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors
AU2022291933A1 (en) * 2021-06-18 2024-01-18 Memorial Hospital For Cancer And Allied Diseases Methods of generating sacral neural crest lineages and uses thereof
EP4573186A1 (en) * 2022-08-16 2025-06-25 The Regents Of The University Of California Cell compositions and methods of using the same
WO2025170529A1 (en) 2024-02-09 2025-08-14 Hedlund Eva A method for deriving a multipotent neuromesodermal progenitor cell and/or daughter lineages, and related compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023568A2 (en) * 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
CN101066472B (zh) * 2007-04-18 2010-05-19 中国人民解放军第二军医大学 组织工程化周围神经移植体及其制备方法
JP5751548B2 (ja) * 2009-08-07 2015-07-22 国立大学法人京都大学 イヌiPS細胞及びその製造方法
WO2011046189A1 (ja) * 2009-10-15 2011-04-21 国立大学法人京都大学 神経変性疾患のモデル細胞、その製造方法及びその用途
CN102191217A (zh) * 2010-03-12 2011-09-21 上海市第一人民医院 一种诱导脐带间充质干细胞分化为类神经细胞的方法
DK2577318T3 (da) * 2010-05-25 2019-10-07 Memorial Sloan Kettering Cancer Center Fremgangsmåde til nociceptor-differentiering af humane embryoniske stamceller og anvendelser deraf
BR112013008957A2 (pt) * 2010-10-15 2019-09-24 Univ Cornell composições e métodos para tratamento de doenças endócrinas, gastrointestinais ou autoimunes
WO2012112933A1 (en) * 2011-02-18 2012-08-23 The Scripps Research Institute Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
EP2614829A1 (en) * 2012-01-11 2013-07-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons
KR20160033703A (ko) * 2013-07-23 2016-03-28 에프. 호프만-라 로슈 아게 체세포로부터 신경 능선 세포로의 소분자 기반 전환
WO2015017523A1 (en) * 2013-07-30 2015-02-05 Waters Technologies Corporation Check valve having polymeric seat and poppet
GB201318126D0 (en) * 2013-10-14 2013-11-27 Univ Cardiff Neuronal Stem Cell Differentiation
CA2931334A1 (en) 2013-11-21 2015-05-28 Memorial Sloan-Kettering Cancer Center Specification of functional cranial placode derivatives from human pluripotent stem cells
US10675382B2 (en) * 2014-09-12 2020-06-09 Kyoto Prefectural Public University Corporation Schwann cells and method for preparing same
US20180140637A1 (en) * 2015-05-19 2018-05-24 Maya Sieber-Blum Epidermal neural crest stem cells as a source of schwann cells
KR101903458B1 (ko) * 2017-01-20 2018-10-02 한국생명공학연구원 슈반 세포 전구체 (Schwann cell precursor) 및 이로부터 분화된 슈반 세포 (Schwann cell)의 제조 방법

Similar Documents

Publication Publication Date Title
JP2019535265A5 (enExample)
Ebert et al. EZ spheres: a stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs
Galiakberova et al. Neural stem cells and methods for their generation from induced pluripotent stem cells in vitro
Chang et al. Neurogenic differentiation of dental pulp stem cells to neuron-like cells in dopaminergic and motor neuronal inductive media
Lang et al. Differentiation of embryonic stem cells to a neural fate: a route to re‐building the nervous system?
Gorris et al. Pluripotent stem cell‐derived radial glia‐like cells as stable intermediate for efficient generation of human oligodendrocytes
Itsykson et al. Derivation of neural precursors from human embryonic stem cells in the presence of noggin
Pollard et al. Adherent neural stem (NS) cells from fetal and adult forebrain
Elkabetz et al. Human ESC-derived neural rosettes and neural stem cell progression
Erceg et al. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions
Dhara et al. Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures
Yang et al. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats
Yamanaka et al. Pluripotency of embryonic stem cells
US8426200B2 (en) Neuronal differentiation of stem cells
Gil et al. Vitronectin promotes oligodendrocyte differentiation during neurogenesis of human embryonic stem cells
US20190017020A1 (en) Differentiation of human pluripotent stem cells to multipotent neural crest cells
CN102307990A (zh) 从干细胞衍生分化细胞的方法
Sundberg et al. Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium
Lukovic et al. Highly efficient neural conversion of human pluripotent stem cells in adherent and animal-free conditions
Noisa et al. Neural progenitor cells derived from human embryonic stem cells as an origin of dopaminergic neurons
Świerczek et al. From pluripotency to myogenesis: a multistep process in the dish
Vergaño-Vera et al. Fibroblast growth factor-2 increases the expression of neurogenic genes and promotes the migration and differentiation of neurons derived from transplanted neural stem/progenitor cells
Shimada et al. Differentiation of dopaminergic neurons from human embryonic stem cells: modulation of differentiation by FGF-20
Axell et al. A method for rapid derivation and propagation of neural progenitors from human embryonic stem cells
Shiraki et al. Differentiation and characterization of embryonic stem cells into three germ layers